Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriaan G Holleboom

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Clinics in Liver Disease|May 16, 2026
Metabolic Liver Disease Beyond the Liver: Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Cardiovascular and Renal DiseasesAmalia Gastaldelli, Frank Tacke, Adriaan G Holleboom
Alimentary Pharmacology & Therapeutics|August 3, 2019
Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver diseaseNienke Koopman, Antonio Molinaro, Max Nieuwdorp, et al.
Trends in Endocrinology and Metabolism: TEM|October 22, 2019
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?Daniela Stols-Gonçalves, G Kees Hovingh, Max Nieuwdorp, et al.
Frontiers in Nutrition|August 9, 2021
Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisVeera Houttu, Susanne Csader, Max Nieuwdorp, et al.
Current Opinion in Lipidology|September 19, 2017
New insights into the role of glycosylation in lipoprotein metabolismMarjolein A W van den Boogert, Daniel J Rader, Adriaan G Holleboom
Journal of Lipid Research|April 8, 2010
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Menno Vergeer, Adriaan G Holleboom, John J P Kastelein, et al.
Cardiovascular Research|September 4, 2020
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosisAngela Pirillo, Monika Svecla, Alberico Luigi Catapano, et al.
United European Gastroenterology Journal|October 5, 2021
Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver diseaseAnne-Marieke van Dijk, Jörn M Schattenberg, Adriaan G Holleboom, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 25, 2019
Moving Targets: Recent Advances in Lipid-Lowering TherapiesLars E Larsen, Robert M Stoekenbroek, John J P Kastelein, et al.
BMJ Case Reports|August 22, 2012
Tuberculous meningitis: treat upon suspicionMyrthe Elisabeth Sonneveld, S M Zinkstok, F J B Nellen, et al.
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Clinics in Liver Disease|May 16, 2026
Metabolic Liver Disease Beyond the Liver: Association of Metabolic Dysfunction-Associated Steatotic Liver Disease with Cardiovascular and Renal DiseasesAmalia Gastaldelli, Frank Tacke, Adriaan G Holleboom
Alimentary Pharmacology & Therapeutics|August 3, 2019
Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver diseaseNienke Koopman, Antonio Molinaro, Max Nieuwdorp, et al.
Trends in Endocrinology and Metabolism: TEM|October 22, 2019
NAFLD and Atherosclerosis: Two Sides of the Same Dysmetabolic Coin?Daniela Stols-Gonçalves, G Kees Hovingh, Max Nieuwdorp, et al.
Frontiers in Nutrition|August 9, 2021
Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-AnalysisVeera Houttu, Susanne Csader, Max Nieuwdorp, et al.
Current Opinion in Lipidology|September 19, 2017
New insights into the role of glycosylation in lipoprotein metabolismMarjolein A W van den Boogert, Daniel J Rader, Adriaan G Holleboom
Journal of Lipid Research|April 8, 2010
The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Menno Vergeer, Adriaan G Holleboom, John J P Kastelein, et al.
Cardiovascular Research|September 4, 2020
Impact of protein glycosylation on lipoprotein metabolism and atherosclerosisAngela Pirillo, Monika Svecla, Alberico Luigi Catapano, et al.
United European Gastroenterology Journal|October 5, 2021
Referral care paths for non-alcoholic fatty liver disease-Gearing up for an ever more prevalent and severe liver diseaseAnne-Marieke van Dijk, Jörn M Schattenberg, Adriaan G Holleboom, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 25, 2019
Moving Targets: Recent Advances in Lipid-Lowering TherapiesLars E Larsen, Robert M Stoekenbroek, John J P Kastelein, et al.
BMJ Case Reports|August 22, 2012
Tuberculous meningitis: treat upon suspicionMyrthe Elisabeth Sonneveld, S M Zinkstok, F J B Nellen, et al.
Pageof 10